A validation study to evaluate a novel cancer screening using C. elegans

A validation study to evaluate a novel cancer screening using C. elegans - A validation study to evaluate a novel cancer screening using C. elegans

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027596

Enrollment

900

Registered

2017-06-01

Start date

2017-06-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All malignancies

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. all patients who visit our hospital. 2. patients who consent to this study. 3. In the cancer patients, Informed consent is carried out and the fact of cancer is announced.

Exclusion criteria

Exclusion criteria: 1. the one who can not obtain urine sample such as dyalysis patients

Design outcomes

Primary

Measure	Time frame
To calculate the sensitivity and specificity of N-NOSE for various cancers and examine speriority with the existing tumor markers.	—

Countries

Japan

Contacts

Public ContactMasanori Kobayashi

Saitama Medical University International Medical Center Department of Gastroenterology

mkobayashi.gast@tmd.ac.jp042-984-4111

Outcome results